Investors & Media

Investors & Media

Welcome to our investor page

We aspire to individualize cancer medicine

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To translate this idea into reality, we have combined ground-breaking research with cutting-edge technologies to develop pioneering therapeutics for cancer and beyond. As we prove the value of our approach in the clinic, we will continue to build the partnerships, manufacturing and team required to bring individualized treatments to patients worldwide. From our roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine.


Stock Quote

Dec 10, 2019 /

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events

January 12 - January 16, 2020

J.P. Morgan 38th Annual Healthcare Conference

The Westin St. Francis Union Square, San Francisco

Upcoming events (more)

Press Releases

14 November 2019

BioNTech SE Provides Update on Corporate Progress and Third Quarter 2019 Financ..

7 November 2019

BioNTech to Report Third Quarter 2019 Financial Results and Operational Progres..

10 October 2019

BioNTech Announces Pricing of Initial Public Offering

Press releases (more)